Home LiteratureArticle Details
PMID: 4953610 Published · ppublish English Journal Article

Lymphocytic-choriomeningitis virus in hamster tumor: spread to hamsters and humans.

Science (New York, N.Y.) ·Vol. 150 ·No. 3694 ·1965-10-15 ·Pages 363-4

Lewis AM, Rowe WP, Turner HC, Huebner RJ

Abstract

A passage line of a spontaneous hamster fibrosarcoma is contaminated by the virus. of lymphocytic choriomeningitis. Tumors from animals receiving implants when newborn contain high titers of infectious lymphocytic-choriomeningitis virus and complement-fixing antigen, and hamsters receiving implants when weanlings develop high titers of complement-fixing antibody against lymphocytic-choriomeningitis virus. In contrast with the specific reactions of tumorous hamsters to the initiating virus in virus-induced tumors, the development of complement-fixing antibody to lymphocytic-choriomeningitis virus does not depend on the development of tumors. Infant hamsters bearing the tumor have a generalized subclinical infection and seem able to spread virus to other hamsters and to humans.

MeSH Terms
Animals Animals, Newborn Antigens Complement Fixation Tests Cricetinae Fibrosarcoma/immunology Humans In Vitro Techniques Lymphocytic Choriomeningitis Neoplasm Transplantation Neoplasms, Experimental/immunology Viruses/immunology Viruses, Unclassified/immunology
Chemicals
Antigens
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Lewis A M
Rowe W P
Turner H C
Huebner R J
Article Info
Journal
Science (New York, N.Y.)
Abbr.
Science
ISSN
0036-8075
Published
1965-10-15
Pages
363-4
Language
English
Region
United States
NLM ID
0404511
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]